Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Temporally restricted activation of IFNβ signaling underlies response to immune checkpoint therapy in mice
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-08-20
DOI
10.1038/s41467-022-32567-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma
- (2021) Kevin Bi et al. CANCER CELL
- A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer
- (2021) Ayse Bassez et al. NATURE MEDICINE
- scCODA is a Bayesian model for compositional single-cell data analysis
- (2021) M. Büttner et al. Nature Communications
- Top 10 Challenges in Cancer Immunotherapy
- (2020) Priti S. Hegde et al. IMMUNITY
- Bilateral murine tumor models for characterizing the response to immune checkpoint blockade
- (2020) Rachael M. Zemek et al. Nature Protocols
- Single-cell transcriptomics identifies an effectorness gradient shaping the response of CD4+ T cells to cytokines
- (2020) Eddie Cano-Gamez et al. Nature Communications
- Monocyte-derived macrophages promote breast cancer bone metastasis outgrowth
- (2020) Ruo-Yu Ma et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Circulating immune cell phenotype dynamics reflect the strength of tumor–immune cell interactions in patients during immunotherapy
- (2020) Jason I. Griffiths et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment
- (2020) Yan Qu et al. Cell Reports
- Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- (2020) Jeong Seok Lee et al. Science Immunology
- A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade
- (2020) Ivy X. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genomic correlates of response to immune checkpoint blockade
- (2019) Tanya E. Keenan et al. NATURE MEDICINE
- Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
- (2019) Timothy F. Cloughesy et al. NATURE MEDICINE
- Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade
- (2019) Brian C. Miller et al. NATURE IMMUNOLOGY
- Remodeling of epigenome and transcriptome landscapes with aging in mice reveals widespread induction of inflammatory responses
- (2019) Bérénice A. Benayoun et al. GENOME RESEARCH
- Sensitization to immune checkpoint blockade through activation of a STAT1/NK axis in the tumor microenvironment
- (2019) Rachael M. Zemek et al. Science Translational Medicine
- Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade
- (2019) Nicolas Jacquelot et al. CELL RESEARCH
- Targeting interferons as a strategy for systemic sclerosis treatment
- (2018) Marzena Ciechomska et al. IMMUNOLOGY LETTERS
- Integrating single-cell transcriptomic data across different conditions, technologies, and species
- (2018) Andrew Butler et al. NATURE BIOTECHNOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- Single-cell transcriptomics of the mouse kidney reveals potential cellular targets of kidney disease
- (2018) Jihwan Park et al. SCIENCE
- RNA velocity of single cells
- (2018) Gioele La Manno et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
- (2018) Spencer C. Wei et al. Cancer Discovery
- TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves
- (2018) David P. Enot et al. OncoImmunology
- A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
- (2018) Livnat Jerby-Arnon et al. CELL
- Lost in Translation: Deciphering the Mechanism of Action of Anti-human CTLA-4
- (2018) Sergio A. Quezada et al. CLINICAL CANCER RESEARCH
- IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
- (2017) Mark Ayers et al. JOURNAL OF CLINICAL INVESTIGATION
- Calling time on the immunotherapy gold rush
- (2017) The Lancet Oncology LANCET ONCOLOGY
- SCENIC: single-cell regulatory network inference and clustering
- (2017) Sara Aibar et al. NATURE METHODS
- Differential analysis of RNA-seq incorporating quantification uncertainty
- (2017) Harold Pimentel et al. NATURE METHODS
- Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity
- (2017) W. Joost Lesterhuis et al. NATURE REVIEWS DRUG DISCOVERY
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework
- (2017) Aziz Khan et al. NUCLEIC ACIDS RESEARCH
- Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
- (2017) Chan-Young Ock et al. Nature Communications
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
- (2016) Joseph L. Benci et al. CELL
- Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
- (2016) Rudragouda Channappanavar et al. Cell Host & Microbe
- Near-optimal probabilistic RNA-seq quantification
- (2016) Nicolas L Bray et al. NATURE BIOTECHNOLOGY
- Characterizing transcriptional heterogeneity through pathway and gene set overdispersion analysis
- (2016) Jean Fan et al. NATURE METHODS
- Resolution of inflammation: a new therapeutic frontier
- (2016) James N. Fullerton et al. NATURE REVIEWS DRUG DISCOVERY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
- (2016) Yuliya V. Katlinskaya et al. Cell Reports
- Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery
- (2016) Suzanne I.S. Mosely et al. Cancer Immunology Research
- Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection
- (2015) Cherie T. Ng et al. Cell Host & Microbe
- Translational Implications of Tumor Heterogeneity
- (2015) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- The BioMart community portal: an innovative alternative to large, centralized data repositories
- (2015) Damian Smedley et al. NUCLEIC ACIDS RESEARCH
- Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations
- (2015) W. Joost Lesterhuis et al. Scientific Reports
- Immune Responses to HCV and Other Hepatitis Viruses
- (2014) Su-Hyung Park et al. IMMUNITY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- GSVA: gene set variation analysis for microarray and RNA-Seq data
- (2013) Sonja Hänzelmann et al. BMC BIOINFORMATICS
- An expression atlas of human primary cells: inference of gene function from coexpression networks
- (2013) Neil A Mabbott et al. BMC GENOMICS
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Synergistic Effect of CTLA-4 Blockade and Cancer Chemotherapy in the Induction of Anti-Tumor Immunity
- (2013) W. Joost Lesterhuis et al. PLoS One
- Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
- (2013) E. B. Wilson et al. SCIENCE
- Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
- (2013) J. R. Teijaro et al. SCIENCE
- A novel significance score for gene selection and ranking
- (2012) Yufei Xiao et al. BIOINFORMATICS
- Wisdom of crowds for robust gene network inference
- (2012) Daniel Marbach et al. NATURE METHODS
- Molecular signatures database (MSigDB) 3.0
- (2011) A. Liberzon et al. BIOINFORMATICS
- Hive plots--rational approach to visualizing networks
- (2011) M. Krzywinski et al. BRIEFINGS IN BIOINFORMATICS
- BEDTools: a flexible suite of utilities for comparing genomic features
- (2010) Aaron R. Quinlan et al. BIOINFORMATICS
- Inferring Regulatory Networks from Expression Data Using Tree-Based Methods
- (2010) Vân Anh Huynh-Thu et al. PLoS One
- The Immunological Genome Project: networks of gene expression in immune cells
- (2008) Tracy S P Heng et al. NATURE IMMUNOLOGY
- Visualization of IFN production by plasmacytoid versus conventional dendritic cells under specific stimulation conditions in vivo
- (2008) S. Scheu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started